MiniMed shares jump 7.1% as fiscal 2027 revenue tops estimates

Verifying
  • MiniMed Group reported fiscal 2027 first-quarter revenue above analyst expectations.
  • $843 million in sales exceeded consensus by $15.9 million and rose 16.6% year over year.
  • Three firms raised MiniMed price targets while maintaining Buy or Outperform ratings.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.